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Abstract
Tendinopathy is of distinct interest as it describes a painful tendon disease with local tenderness,
swelling and pain associated with sonographic features such as hypoechogenic texture and diameter
enlargement. Recent research elucidated microcirculatory changes in tendinopathy using laser
Doppler flowmetry and spectrophotometry such as at the Achilles tendon, the patellar tendon as
well as at the elbow and the wrist level. Tendon capillary blood flow is increased at the point of
pain. Tendon oxygen saturation as well as tendon postcapillary venous filling pressures, determined
non-invasively using combined Laser Doppler flowmetry and spectrophotometry, can quantify, in
real-time, how tendon microcirculation changes over with pathology or in response to a given
therapy. Tendon oxygen saturation can be increased by repetitive, intermittent short-term ice
applications in Achilles tendons; this corresponds to 'ischemic preconditioning', a method used to
train tissue to sustain ischemic damage. On the other hand, decreasing tendon oxygenation may
reflect local acidosis and deteriorating tendon metabolism. Painful eccentric training, a common
therapy for Achilles, patellar, supraspinatus and wrist tendinopathy decreases abnormal capillary
tendon flow without compromising local tendon oxygenation. Combining an Achilles pneumatic
wrap with eccentric training changes tendon microcirculation in a different way than does eccentric
training alone; both approaches reduce pain in Achilles tendinopathy. The microcirculatory effects
of measures such as extracorporeal shock wave therapy as well as topical nitroglycerine application
are to be studied in tendinopathy as well as the critical question of dosage and maintenance.
Interestingly it seems that injection therapy using color Doppler for targeting the area of
neovascularisation yields to good clinical results with polidocanol sclerosing therapy, but also with
a combination of epinephrine and lidocaine.
Introduction
This review focuses merely on the microcirculatory
changes encountered in Achilles and patellar tendinopa-
thy and its potential modification by different current
treatment options. During the last years there has been
tremendous research in this area. Approaches involved
the term tendinosis which was defined from histopatho-
logic findings involving widening of the tendon, dis-
turbed collagen distribution, neovascularisation and
increased cellularity [1,2]. The severity of these tendon
changes encountered in tendinosis was quantified [3],
and the importance of the ongoing process and cause of
increased cell proliferation was demonstrated [4]. Based
on these reports neovascularisation was 1 out of 4 crite-
ria's of tendinosis, which I will refer to throughout this
review.
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Neovascularisation in tendinopathy
Neovascularisation is one feature of tendinopathy among
others at various anatomic sites, such as the Achilles ten-
don, the patella tendon, tendinopathy of the wrist as well
as in tennis elbow. Contemporary ultrasound studies
using colour and/or power Doppler ultrasound identified
neovascularisation among patients suffering Achilles
tendinopathy [5-7] as well as in histological specimens
from Achilles tendon ruptures [8] (table 1).
Neovascularisation was also reported in ultrasound of
patellar tendinopathy with the vessels typically arising
from the Hoffa fat pad [9,10]. The same phenomenon has
been described for lateral elbow tendinopathy [11], flexor
carpi ulnaris tendinopathy of the wrist [12], posterior tib-
ial tendon insufficiency [13], and in supraspinatus tendon
overuse [14] determined by colour and/or power Doppler
ultrasound techniques. Currently, there is reasonable
published evidence that the neovessels are at least part of
the pathophysiological process in tendinopathy of the
Achilles tendon in its mid-portion area, at the patella ten-
don and in tendinopathies of the upper extremity such as
in tennis elbow or in tendinopathies at the wrist level.
The diagnosis of tendinopathy of the main body of the
Achilles tendon is made if patients have Achilles tendon
pain at rest or at exercise in the main body of the Achilles
tendon, 2–6 cm proximal to the insertion, associated with
tenderness and swelling. In contrast, insertional tendin-
opathy of the Achilles tendon might involve various dis-
tinct clinical entities besides mere insertional tendon
problems associated with neovascularisation. This distinct
entity such as Haglund's exostosis or bursitis subachillae
does not necessarily involve neovascularisation. There-
fore, all insertional Achilles tendon problems reported in
this review are tendon problems with neovascularisation
arising from tiny vessels from the ventral aspect of the
Achilles tendon in the Karger triangle with increased cap-
illary blood flow.
The importance of structures close to the Achilles tendon
and the "communication" in between and the role of the
skin barrier, subcutis, as well as the paratenon is impor-
tance in this regard [15]. However, currently one has to be
aware that the cells and biology which controls these extra
and intra tendinous processes are only poorly under-
stood. We do not even know what type of cells we find in
the diseased tendons or how they work, and several up
and down regulating factors, extrinsic and extrinsic factors
may be involved.
What drives the phenomenon of neovascularisation?
I use the term 'neovascularisation' as a descriptive term for
the appearance of abnormal vessels [16] and 'angiogen-
esis' for the process by which this occurs. Angiogenesis is
known to be controlled by several stimulatory and inhib-
itory proteins [17-19] (table 2). Inhibition of angiogen-
esis is necessary for the development and maintenance of
hypo- or avascular tissues. This might be caused either by
production of an inhibitory factor or by a reduction of the
angiogenesis factor.
The angiogenesis factor (vascular endothelial growth fac-
tor (VEGF) is expressed in fetal but not in adult tendons
[20,21]. In adult tendons, the anti-angiogenesis factor
endostatin is expressed [22] – especially in the gliding area
of gliding tendons. Endostatin is a 20 kDa proteolytic
fragment of collagen type XVIII with strong anti-ang-
iogenic potency [23,24]. Endostatin inhibits prolifera-
tion, migration and apoptosis of endothelial cells.
Endostatin also interacts with VEGF signal transduction
by reducing VEGF-induced kinase (Erk1/2) phosphoryla-
tion [25]. Therefore, a complex balance between pro- and
antiangiogenesis factors are involved in neovascularisa-
tion and this is reviewed by Pufe [26].
Close relation between nerves and vessels
Mechanoreceptors and nerve-related components such as
glutamate NMDA receptors are present in association with
blood vessels in tendinopathic tendons [27,28]. In tennis
Table 1: Distribution of Tendon Pathologic Scores in control and ruptured Achilles tendons
Variable Control tendon (N = 46) Ruptured tendon (N = 38)
012 3 0 12 3
Fiber structure 19 19 4 4 0 1 11 26
Fiber arrangement 19 19 4 4 0 1 11 26
Rounding of the nuclei 19 15 9 3 0 0 4 34
Regional variations in cellularity 23 12 8 3 0 0 9 29
Increased vascularity 26 10 9 1 0 0 6 32
Decreased collagen stainability 15 20 10 1 0 2 12 24
Hyalinization 19 21 5 1 0 5 25 8
GAG content 22 15 8 1 0 7 26 5
a The worst scoring result was used in each situation.Journal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
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elbow, substance P and its receptor (neurokinin-1-recep-
tor) could be detected using immunostaining as well as
interleukin-1 alpha and TGF beta 1 positive cells in small
vessels [29]. Recently, the Umea research group described
the distribution of general (PGP 9.5) and sensory (sub-
stance P/CGRP) innervations in the human patellar ten-
don [30]. They proposed that there was nerve-mediated
regulation of the blood vessels supplying the tendon, at
the level where they course in the loose paratendinous
connective tissue. The same authors also demonstrated an
up-regulation of the cholinergic system as well as the pres-
ence of autocrin/paracrine effects in patellar tendinopathy
[31].
Recent publications suggest that the vascular in-growth in
tendinopathy, in other words the neovascularisation, is
accompanied with a nerval in-growth facilitating pain
transmission in Achilles tendionpathy [32] and patella
tendinopathy [33]. In other words we encounter a neuro-
vascular inflammatory reaction in tendinopathy. Cur-
rently, based on the published reports, we cannot deter-
mine whether the vascularisation or the neurogenic
component or both are the predominant factor in tendin-
opathy. One could speculate that with a resolution of the
neovascularisation by a given treatment option such as
eccentric training or sclerosing therapy, which I refer to
later, the closely associated nerve endings will be dis-
turbed or even destroyed due to a lack of perfusion by
their nutrient neovessels. However, currently this is mere
speculation. Alfredson speculated that eccentric training
might traction the area of neovessels and be responsible
for the good clinical results [34] but this hypothesis
remains untested based on the current published reports.
Diagnostic tools for microcirculatory assessment
Conventional ultrasound for tendon assessment in tendi-
nopathy reveals hypoechogenic texture within an
enlarged tendon especially in the anterior-posterior diam-
eter. Power Doppler technology is capable in identifying
neovascularisation in tendinopathic tendons because it
allows visualisation of low-flow vessels by far more accu-
rate than conventional colour Doppler ultrasound. In the
Achilles tendon, these neovessels typically arise from the
ventral and paratendinous portion leading into the Achil-
les tendon body. In patella tendinopathy these neovessels
often arise inferior to the patella from the Hoffa fat pad
entering the patella tendon in a 60°–90° angle. Magnetic
resonance tomography determines tendon signal changes
as well as paratendinous fluid with the signal intensity
being the important factor in current tendinopathy MRI.
Intratendinous pattern changes may be also depicted
using MRI. Furthermore, volume calculations can be done
using MRI, as demonstrated for the Achilles tendon by
Shalabi [35].
Among 33 patients with chronic Achilles tendinosis
(mean age 52 yrs) they found that a computerized 3-D
seed growing technique demonstrates an overall excellent
reliability to monitor and evaluate the volume of the
Achilles tendon and the mean intratendinous signal. Fur-
thermore, the same authors reported that both, eccentric
and concentric loading of the Achilles tendon resulted in
an immediately increased tendon volume and intratendi-
nous signal in 22 patients with chronic Achilles tendinop-
athy [36]. The eccentric training regimen was performed
with 3 sets of 15 repetitions of heavy-loaded eccentric
training with an immediate MRI following this exercise
within 30 minutes showing the above mentioned
changes. However, one has to mention that acute tendon
effects even within 30 minutes might not illustrate acute
changes immediately after the exercise. Long term eccen-
tric training decreases the Achilles tendon volume by 14%
and the signal intensity in T1-weighted MRI scans from
6.6 ± 3.1 cm3 to 5.8 ± 2.3 cm3 (p < 0.05).
However, neither conventional ultrasound nor MRI is cur-
rently used for microcirculatory monitoring. Power Dop-
pler is of qualitative use with visualisation of the course of
the neovascularisation, but no quantitative data are
derived by Power Doppler only in its current routine
application.
Microcirculation monitoring
Real-time microcirculation assessment is possible using a
combined non-invasive Laser-Doppler and spectropho-
tometry system, the Oxygen-to-see System (LEA Medizin-
technik, Giessen, Germany, figures 1, 2). Three distinct
parameters of microcirculation can be determined using
the Oxygen-to-see system [37,38] (table 3):
￿ Capillary flow
￿ Tissue oxygen saturation
￿ Postcapillary venous filling pressure
Table 2: Angiogenesis inhibitors and stimulators
Angiogenesis inhibitors Angiogenesis stimulators
Chondromodulin-1 Metalloproteinase-9
Thrombospondin-1 Metalloproteinase-14
Thrombospondin.2 MT1-Metalloproteinase
Tissue inhibitor of 
metalloproteinases-1
Vascular endothelial growth factor-A
Tissue inhibitor of 
metalloproteinases -2
Tissue inhibitor of 
metalloproteinases -3
EndostatinJournal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
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However, one has to consider that these three microcircu-
latory do not necessarily display the complete microcircu-
latory environment, since vascular factors such as clotting,
adhesion, thrombus formation and several others are not
addressed by the aforementioned mere non-invasive tech-
nique.
Capillary blood flow
Laser-Doppler flowmetry has been introduced for deter-
mination of capillary flow in various disease states. Stern
has applied the Doppler effect to study in the microcircu-
lation as early as 1975 in his Nature paper [39]. Validation
work has been done extensively in the following, stating
that the Laser Doppler method is a promising tool for
rapid monitoring of dynamic changes in tissue perfusion"
[40].
Piloting the laser Doppler application to the tendon scien-
tific area, Astrom and Svensson from the Malmo General
hospital in Sweden studied the Laser Doppler flowmetry
to the Achilles tendon surface of ten mature albino rats
[41]. Clamping the femoral artery resulted in a 60%
reduction of tendon blood flow and consecutive hyperae-
mia following clamp release in reperfusion. In circulatory
arrest, no tendon flow was determined in this pilot study
of Laser Doppler application in the tendon area.
Three years later, in 1994, Astrom and Westlin [42]
reported about their initial experience at rest, during vas-
cular occlusion, and during passive stretch and isometric
contraction of the triceps surae among 40 healthy volun-
teers. They used an invasive needle probe, which was
placed 5 mm above the distal insertion of the Achilles ten-
don, at the midportion and the musculotendineus junc-
Table 3: Overview regarding three microcirculatory changes and its physiological effect on the tendon.
Microcirculatory change Physiological effect on the tendon
Capillary tendon flow↑ Potential harmful, increases pain by aggravation of neovascularisation
Capillary tendon flow↓ Beneficial, decreases pain by reducing neovascularisation, might harm the tendon at very low levels 
(threshold yet undetermined), achieved by cryotherapy and compression as well as eccentric training only
Tendon oxygenation↑ Beneficial, tendon oxygenation is increased, the resistance against ischemia is increased, hyperaemia is 
beneficial, achieved by combined cryotherapy and compression as well as eccentric training and Achilles 
wrap
Tendon oxygenation↓ Harmful, limits tendon oxygenation, increases lactate levels with acidosis, following ischemia
Postcapillary venous filling pressure↑ Harmful, increased pressure decreases clearance of local metabolic end products, consecutive increase in 
capillary flow following venous congestion, facilitating of infections and wound problems due to local stasis 
in venous congestion, increased in thrombosis and postthrombotic state
Postcapillary venous filling pressure↓ Beneficial, since clearance of metabolic end products is facilitated, achieved by cryotherapy and compression 
as well as by eccentric training and Achilles wrap
Oxygen-to-see probe, a combined laser Doppler and spec- trophotometry system to determine Achilles microcircula- tion non-invasively Figure 1
Oxygen-to-see probe, a combined laser Doppler and spec-
trophotometry system to determine Achilles microcircula-
tion non-invasively.
Oxygen-to-see system combining Laser Doppler flowmetry  and spectrophotometry non-invasively to determine tendon  capillary blood flow, tendon oxygen saturation, and tendon  postcapillary venous filling pressures Figure 2
Oxygen-to-see system combining Laser Doppler flowmetry 
and spectrophotometry non-invasively to determine tendon 
capillary blood flow, tendon oxygen saturation, and tendon 
postcapillary venous filling pressures.Journal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
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tion of both legs, one of the first studies ever to
differentiate between insertional and mid-portion loca-
tions. Astrom reported a significantly lower tendon blood
flow at the insertion, but otherwise even vascular distribu-
tion. Vascular occlusion reduced all Achilles tendon blood
flow values. Interestingly, passive stretch and isometric
contraction induced a progressive decline in capillary ten-
don blood flow determined by laser Doppler flowmetry
in this initial study. Hyperaemia was often noted by
Astrom following contraction with higher tendon blood
flow among women and a decreasing blood flow with
increasing age. However, one has to bear in mind that
only healthy volunteers participated in this study.
The reduced capillary tendon blood flow with increasing
age is of special interest, since a decreased capillary tendon
blood flow with increasing age might imply a consecutive
malperfusion with age, thus leading to tendinopathy and
finally to tendon rupture. On the other hand, as will be
demonstrated in the following, we found that in sympto-
matic tendinopathy neovascularisation is associated with
a significantly increased capillary blood flow in the Achil-
les tendon at the point of pain [43] (figure 3). Tendon
repair, such as minimal-invasive percutaneous in com-
plete Achilles tendon rupture, changes Achilles microcir-
culation in a time-dependent manner (figure 4).
The distribution of tendon capillary blood flow was per-
formed in an Achilles tendon mapping technique, evalu-
ating four tendinous and eight corresponding
paratendinous location throughout the Achilles tendon.
In contrast to histological data from staining suggesting
that within the mid-portion part of the Achilles tendon
the perfusion is limited [44,45], which favours Achilles
tendon ruptures in the mid-portion area due to its relative
malperfusion. This was stated by the anatomical studies
by Lang and supported by a plastination study from Hei-
delberg, Germany [46]. They studied the vascular anat-
omy of eight human specimens suing a plastination
perfusion method through the femoral artery. They iden-
tified the well-vascularized paratendon with a large
number of intra- and extratendinous anastomosis. Micro-
circulatory effects on the capillary flow have been
described in cardiac surgery, where retrosternal capillary
flow is reduced by 50% following harvesting of the inter-
nal thoracic artery for coronary revascularisation [47].
Recently we could demonstrate the successful combined
Superficial (upper numbers [rE as arbitrary unit]) and deep  (lower numbers) capillary flow at the second postoperative  day following minimal invasive percutaneous Achilles tendon  repair at the left leg Figure 4
Superficial (upper numbers [rE as arbitrary unit]) and deep 
(lower numbers) capillary flow at the second postoperative 
day following minimal invasive percutaneous Achilles tendon 
repair at the left leg.
Capillary tendon blood flow in mid-portion symptomatic  Achilles tendinopathy (left tendon) vs. the corresponding  asymptomatic contralateral Achilles tendon in 50 patients  with Achilles mid-portion tendinopathy Figure 3
Capillary tendon blood flow in mid-portion symptomatic 
Achilles tendinopathy (left tendon) vs. the corresponding 
asymptomatic contralateral Achilles tendon in 50 patients 
with Achilles mid-portion tendinopathy.Journal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
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sclerosing therapy with polidocanol followed by a 12-
week eccentric training in a tennis player suffering tremen-
dous pain due to flexor carpi ulnaris tendinopathy [12].
Considering tendon oxygen saturation and postcapillary
venous filling pressures besides capillary blood flow one
has to acknowledge that each microcirculatory parameter
is independent from each other. However, pathophysio-
logical relations are evident such as in the case of
ischemia, where a decrease of capillary blood flow due to
arterial vessel obstruction is followed by a decrease of tis-
sue oxygenation [48]. A venous stasis such as a venous
thrombosis increases postcapillary venous filling pres-
sures with consecutive decrease of oxygen saturation due
to venous congestion and subsequent decreased capillary
inflow in the further course.
Tissue oxygen saturation
Tissue oxygen saturation is attributed as the local oxygen
content of the focussed tissue. Tissue oxygen saturation
has been determined using different probes and tech-
niques. In 1987, Stone and coworkers from the Brigham
and Women's Hospital in Boston, MA determined the ten-
don and ligament oxygenation using invasive polaro-
graphic oxygen sensors [49]. First, they started with
tendon oxygen saturation determination in the Achilles
tendon of the sheep, where they found a 100% (13 of 13
events) response rate to changes of blood flow with con-
secutive oxygen saturation reduction. Second, they moved
to the human anterior cruciate ligament, where they
placed the invasive probe in five human knees during
routing total knee replacement. In 83% of the cases (5 of
6 events) the oxygen saturation response was appropriate
to the tourniquet placement.
Non-invasive tissue oxygen saturation is determined by
spectrophotometry in the Oxygen-to-see System.
Ischemia decreases oxygen saturation dramatically (figure
5). Repetitive ischemia and reperfusion, which is called
preconditioning is capable in increasing tissue oxygena-
tion (figure 6). Tendon oxygenation therefore is a marker
for local oxygen content. A decrease of tendon oxygena-
tion is potential harmful, since this is a sign for local aci-
dosis. High intratendinous lactate levels have been
reported in painful chronic Achilles tendinopathy by
Alfredson17. Normal prostaglandin E2 levels have been
identified by in vivo microdialysis as well] questioning
the tons of non-steroidal anti-inflammatory drugs
(NSAIDs) prescribed for this condition [50]. As aforemen-
tioned one has to acknowledge that tendon oxygen satu-
ration may change independent of capillary blood flow as
vice versa. Recently, an increase of Achilles tendon satura-
tion has been reported after repetitive contractions among
twelve men [51].
Postcapillary venous filling pressures (rHb)
Venous congestion causes venous stasis, which is part of
inflammation. Capillary venous stasis deteriorates local
capillary clearance of local metabolic end products. On
the other hand, decreased postcapillary venous filling
pressures are beneficial, since local clearance is facilitated.
In disease states, increased postcapillary venous filling
pressures have been encountered in the retrosternal
region following removal of the internal thoracic artery
and vein for coronary revascularisation [48]. Decreased
postcapillary venous filling pressures of the mid-portion
Achilles tendon are encountered using simultaneous cry-
otherapy and compression over 10 minutes [52]. Achilles
tendon postcapillary venous filling pressures were signifi-
cantly reduced following a 12 week eccentric training at
the Achilles tendon insertion (51 ± 16 vs.41 ± 19, p =
0.001) and the distal mid-portion (36 ± 13vs.32 ± 12, p =
0.037) at 2 mm and at the insertion of the Achilles tendon
at 8 mm (63 ± 19vs.51 ± 13, p = 0.0001) [53].
Gender and Achilles tendon microcirculation
Based on the higher ligament injury rate among females
vs. males such as for the anterior cruciate ligament injury
Myocardial oxygen saturation (SO2%) following 5 min (red),  15 min (yellow) and 30 min (green) of ischemia following  clamping of the left descending coronary artery and reper- fusion with decreased baseline myocardial oxygen saturation  after 15 and 30 min of ischemia indicating an ischemia- induced damage to the myocardium (Knobloch K, unpub- lished data) Figure 5
Myocardial oxygen saturation (SO2%) following 5 min (red), 
15 min (yellow) and 30 min (green) of ischemia following 
clamping of the left descending coronary artery and reper-
fusion with decreased baseline myocardial oxygen saturation 
after 15 and 30 min of ischemia indicating an ischemia-
induced damage to the myocardium (Knobloch K, unpub-
lished data).Journal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
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we thought to evaluate the effect of gender on tendons.
We found that symptomatic female patients suffering
mid-portion Achilles tendinopathy have similarly ele-
vated tendon capillary blood flow compared with symp-
tomatic male patients suffering Achilles tendinopathy,
but superior tendon and paratendon oxygen saturations
and reduced postcapillary venous filling pressures indi-
cate better tendon and paratendon Achilles tendon micro-
circulation in women [54]. Therefore, symptomatic
females do not have worse, but equal or even superior
Achillles tendon microcirculation compared to sympto-
matic males.
Tendinopathy treatment based on microcirculatory changes
Eccentric training
Eccentric training is used to treat Achilles, patella, shoul-
der [55], and wrist tendinopathy. On a microcirculatory
level, Achilles tendon capillary blood flow was signifi-
cantly reduced at the insertion (by 35%, p = 0.008, figure
7) and the distal mid-portion area (by 45%, p = 0.015) at
2 mm and by 22% (p = 0.007) and 13% (p = 0.122) at 8
mm tissue depths [56]. Achilles tendon oxygen saturation
was not decreased after the 12-week-eccentric-training
regimen throughout the insertion to the proximal mid-
portion area (insertion: 72 ± 13 vs.73 ± 10, proximal mid-
portion 63 ± 13 vs.62 ± 11, both n.s., figure 8). Achilles
tendon postcapillary venous filling pressures were signifi-
cantly reduced at the insertion (51 ± 16 vs.41 ± 19, p =
0.001) and the distal mid-portion (36 ± 13 vs.32 ± 12, p
= 0.037) at 2 mm and at the insertion at 8 mm (63 ± 19
vs.51 ± 13, p = 0.0001). No increase of tendon postcapil-
lary venous filling pressure was noted which would be
harmful.
Non-invasive conservative cryo/compression
Twenty-six subjects were included (32.3 ± 12 yrs, BMI
25.4 ± 5) with three ten-minute applications simultane-
Achilles tendon oxygen saturation before (left) and after  (right) 12 weeks of daily painful eccentric training in chronic  Achilles tendinopathy in 59 patients with symptomatic 64  tendons Figure 8
Achilles tendon oxygen saturation before (left) and after 
(right) 12 weeks of daily painful eccentric training in chronic 
Achilles tendinopathy in 59 patients with symptomatic 64 
tendons.
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Achilles tendon capillary blood flow at 2 mm depth before  (left) and after (right) 12 weeks of daily painful eccentric  training in chronic Achilles tendinopathy among 59 patients  with symptomatic 64 tendons Figure 7
Achilles tendon capillary blood flow at 2 mm depth before 
(left) and after (right) 12 weeks of daily painful eccentric 
training in chronic Achilles tendinopathy among 59 patients 
with symptomatic 64 tendons.
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ous cryotherapy and compression using the Aircast™
Cryo/Cuff ankle device, each followed by a 10 minute
recovery period and continuous real-time assessment of
parameters of Achilles tendon mid-portion microcircula-
tion using a laser-Doppler-spectrophotometry-system
(O2C, Germany) [53].
Superficial tendon oxygen saturation dropped signifi-
cantly from 35.9 ± 21% to 13.5 ± 15/15.9 ± 16 and 11.1 ±
11% (p = 0.0001) during each period of cryo-compres-
sion respectively with significant increase during recovery
period (55.4 ± 29/65.2 ± 26 and 65.7 ± 27%, p = 0.003)
up to +83% of the baseline level. At 8 mm tendon depth,
cryo-compression preserved local oxygen with -4% (p =
0.001) of the baseline level and small, but significant
increased oxygen saturation of up to +13% (p = 0.0001).
Relative postcapillary venous tendon filling pressures
were favourably reduced to 57 ± 34%/67 ± 27 and 64 ±
38% (p = 0.0004) superficially and deep (76 ± 13%/79 ±
11 and 78 ± 18%, p = 0.0002). Superficial capillary blood
flow was reduced from 48.4 ± 48 to 5 ± 7/4 ± 5 and 3 ± 4
(-94%, p = 0.0003) with increased flow during recovery
periods of up to 58 ± 64/58 ± 79 and 47 ± 71 (+20%, p =
0.265). Deep flow was reduced from 197 ± 147 to 66.7 ±
64/55 ± 46 and 43 ± 39 (-78%, p = 0.0002) without
increase during recovery periods.
Intermittent Cryo/Cuff™ administration of 3 × 10 min sig-
nificantly decreased local Achilles tendon capillary blood
flow by 90% with a subsequent small hyperaemia. Post-
capillary venous filling pressures are reduced during Cryo/
Cuff™ favouring venous outflow. Deep Achilles tendon
oxygen supply is not impaired by Cryo/Cuff™ which is
beneficial. Therefore, Cryo/Cuff™ exerts beneficial effects
on the microcirculatory level of the mid-portion Achilles
tendon with decreased capillary blood flow, preserved
deep tendon oxygen saturation and facilitated venous cap-
illary outflow.
Non-invasive conservative Achilles wrap
112 subjects were recruited in a prospective randomized
yet unpublished trial (figure 9). We hypothesized whether
the additional use of an Achilles wrap with two intercon-
nected air cells located under the foot arch and at the
Achilles tendon, in addition to a daily eccentric training is
superior than an eccentric training alone over a 12-week
period concerning subjective assessment of impairment
according to the Foot and ankle outcome score, pain and
the microcirculatory parameters tendon capillary blood
flow, tendon postcapillary venous filling pressure and ten-
don oxygen saturation.
Group A performed daily eccentric training over 12 weeks
with additional daily Achilles wrap (AirHeel™, AIRCAST,
54 tendons of 54 patients), while group B performed the
same eccentric training only (64 tendons of 59 patients).
91 patients fulfilled the 12-week-training period (81%).
Tendon oxygen saturation increased significantly in group
A at insertion (70 ± 11 vs.75 ± 7%, p = 0.001) and distal
mid-portion (68 ± 12 vs.73 ± 9%, p = 0.006), which was
significantly increased vs. group B distal mid-portion (69
± 11 vs.68 ± 15%, p = 0.041 vs.A). Postcapillary venous
filling pressures were significantly reduced in group A at
5/8 positions at two and eight mm tendon depths (up to
26%, p = 0.003), while only in 3/8 positions in group B
(up to 20%, p = 0.001). Pain on VAS was 5.1 ± 2.1 vs. 3.2
± 2.7 (A, -37.3%, p = 0.0001) vs. 5.5 ± 2.1 vs. 3.6 ± 2.4 (B,
p = 0.0001, -34.6%, p = 0.486 for A vs. B).
Tendon oxygen saturation is increased and capillary
venous clearance facilitated using an Achilles wrap addi-
tionally to a daily 12-week eccentric training. Achilles
wrap and eccentric training increase subjective assessment
of Achilles tendinopathy, however, the pain level reduc-
tion was the same in both groups with no additive effect.
These results are supported by a similar recently published
randomized trial with either AirHeel™ wrap or eccentric
training or the combination of both [57].
Non-invasive topical nitroglycerin in tendinopathy
The rationale for the use of topical transdermal nitroglyc-
erin in tendinopathy is based on the following animal
studies. An increased NOS expression was demonstrated
by Lin and coworkers from Sydney, Australia, at both pro-
tein and mRNA levels during Achilles tendon healing in
macrophages and fibroblasts as well as in the vascular
endothelial cells. All three NOS isozymes were expressed
in a temporal manner in fibroblasts at the healing tendon
[58].
Oxygen-to-see system to determine capillary blood flow,  tendon oxygen saturation and tendon postcapillary venous  filling pressures non-invasively using combined Laser Doppler  flowmetry and spectrophotometry Figure 9
Oxygen-to-see system to determine capillary blood flow, 
tendon oxygen saturation and tendon postcapillary venous 
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flowmetry and spectrophotometry.Journal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
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The first published study to show an effect of 5 mg-nitro-
glycerine patch applied daily for three days was performed
in Santander, Spain among 20 patients with supraspina-
tus tendinopathy with improvement on VAS from 7 ± 0.4
to 2 ± 0.3 within 48 hours [59]. The Orthopedic Research
Team at St. George Hospital in Sydney has started in 2003
to publish randomized-controlled trials regarding the
convincing effects of topical nitric oxide application via a
patch in tennis elbow [60], mid-portion Achilles tendin-
opathy [61], and supraspinatus tendinopathy [62].
Recently, Paoloni and Murrel reported their three-year fol-
low-up data in patients suffering non-insertional Achilles
tendinopathy undergoing topical glyceryl trinitrate treat-
ment over 6 months [63]. Topical glyceryl trinitrate treat-
ment has demonstrated efficacy in treating chronic
noninsertional Achilles tendinopathy, and the treatment
benefits continue at 3 years. Significant differences in
asymptomatic patient outcomes for the glyceryl trinitrate
group continue at 3 years, and this is confirmed by the
effect size estimate. This suggests that the mechanism of
action of topical glyceryl trinitrate on chronic tendinopa-
thies is more than an analgesic effect.
To date, it is unknown whether transdermal nitroglycerine
affects tendon microcirculation besides the above men-
tioned action as a small diffusible molecule. In analogy to
its long-time proven efficacy in vasodilatation of coronary
arteries in coronary artery disease one could speculate that
mainly the capillary blood flow is affected by NO as a
vasodilatory effect. This would imply an increased, rather
than a decreased capillary flow to the tendinopathic ten-
don, which seems, based on the current results, to be not
beneficial. Furthermore, one could speculate that the
vasodilatation is effective for the postcapillary venous sys-
tem, which will decrease postcapillary venous filling pres-
sures and thus, facilitating clearance of metabolic end
products which is favourable. However, to date no micro-
circulatory data are available on this issue.
Non-invasive low level laser therapy
In 1998, a randomized, double-blinded, placebo-control-
led study was performed in the Mayo Clinic, Rochester,
MN in a sports medicine clinic [64]. 32 patients with
plantar fasciitis of more than one year duration were
enrolled. Low-intensity infrared laser therapy appeared
safe but not beneficial regarding morning pain, pain with
toe walking, tenderness to palpation, windlass test
response, medication consumption, and orthotic use
within one months after a for week low level laser therapy.
Recently, two randomized trials were published studying
the effect of low level laser therapy with 904 nm laser on
Achilles tendinopathy [65,66]. Power Doppler sonogra-
phy identified peritendinous and intratendinous arterial
blood flow velocity, which was used to calculate the arte-
rial resistive index which is supposed to be a measure of
vasodilatation and inflammation as (systolic peak veloc-
ity minus end diastolic velocity)/systolic peak velocity,
which was possible at baseline in eight of 14 tendons. The
resistive index in these eight tendons at baseline was 0.91
(95% CI 0.87 to 0.95) indicating a small degree of inflam-
mation.
At baseline, all 14 tendons exhibited an increased peri-
tendinous and intratendinous blood flow. After treat-
ment, the tendinous blood flow appeared to be reduced,
however, no significant differences could be found
between the low level laser group and the placebo group
with only 8 of 14 tendons tested. Prostaglandin E2 levels
as a potential marker of inflammation were reduced fol-
lowing low level laser therapy. Regarding the mechanism
of action, no detailed information was given.
Low level laser therapy has been shown to affect many
subcellular and cellular processes, although the mecha-
nisms have not been well defined [67]. Low level laser
therapy may have physiologic effects mediated by photo-
chemical actions at the cellular level in animal and human
tissues, up-regulating cartilage proteoglycan, collagen,
noncollagen protein, and DNA synthesis in the absence of
histologic or biochemical evidence of enhanced matrix
catabolism in animal studies [68]. However, it is impor-
tant to note that LPLT does not produce significant tissue
temperature changes, so any potential physiological
effects appear to be nonthermal [69]. Therefore, besides
effects on matrix matrix-metalloproteinases, this non-
invasive technique might interfere somehow with the
neovascularisation, may be decreasing the capillary flow
by local thrombosis or partial destruction of the neoves-
sels. Further studies using the detailed microcirculatory
mapping might elucidate this issue.
￿ Invasive sclerosing/coagulation therapy focussing the
area of neovascularisation
Two uncontrolled pilot studies have been published by
Ohberg and Alfredson from Umea, Sweden, in which a
sclerosant agent (polidocanol) was injected outside the
Achilles tendon into the area of neovascularization both
in mid-portion and insertional Achilles tendinopathy
[70,71]. The injections were effective at reducing levels of
pain, presumably as the sclerosant injection was toxic
both to the neovascularization and localized sensory
nerves.
A randomized-controlled trial was recently published
with 32 patients with 42 tendons with chronic patellar
tendinopathy enrolled from Norwegian elite basketball,
handball, and volleyball divisions [72] studyng polidoca-Journal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
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nol sclerosing vs. lidocaine/epinephrine injections under
colour Doppler guidance. Sclerosing with polidocanol
was performed in the area of neovascularisation resulting
in an improved knee function and reduced pain in the
polidocanol group in contrast to the lidocaine/epine-
phrine group.
Two-year follow-up data have been published by Alfred-
son's group recently for polidocanol sclerosing therapy in
mid-portion Achilles tendinopathy [73]. They concluded
that treatment with sclerosing polidocanol injections in
patients with chronic painful mid-portion Achilles tendi-
nosis showed remaining good clinical results at a 2-year
follow-up. Decreased tendon thickness and improved
structure after treatment, might indicate a remodelling
potential.
Whether tendon sclerosing technique causes local throm-
bosis, which would be appreciated by increased postcap-
illary venous filling pressures, or a local destruction of the
capillary flow monitored by decreased capillary flow
velocity, is currently not known. The fact that no
hematoma or organized fluid is appreciated following the
sclerosing technique has to be kept in mind. Interestingly,
Alfredson and Öhberg reported about an increased vascu-
larity in the early period, which is 1–3 weeks after scleros-
ing therapy for Achilles tendinopathy. Gradually
afterwards, in between weeks 4 to 12, the neovascularisa-
Proposed flow chart of tendon degeneration starting with the healthy Achilles tendon and extrinsic a nd/or intrinsic factors  over asymptomatic states with increase in tendon diameter and detectable capillary blood flow and/or Power Doppler flow to  symptomatic states and consecutive tendon rupture Figure 10
Proposed flow chart of tendon degeneration starting with the healthy Achilles tendon and extrinsic a nd/or intrinsic factors 
over asymptomatic states with increase in tendon diameter and detectable capillary blood flow and/or Power Doppler flow to 
symptomatic states and consecutive tendon rupture. Created by Knobloch with accomplishments to Richards et al. 2005, Maf-
fuli et al. 2000, Kannus et Josza 1991.Journal of Orthopaedic Surgery and Research 2008, 3:18 http://www.josr-online.com/content/3/1/18
Page 11 of 13
(page number not for citation purposes)
tion is supposed to be fading. Therefore, the currently rec-
ommend a 6–8 week interval in between the consecutive
polidocanol injections outside the tendon in order to not
interfere with this process. Whether the agent injected
matters is currently undetermined. There have been
reports on sonographically guided intratendinous injec-
tion of hyperosmolar dextrose to treat chronic Achilles
tendinopathy [74]. However, potential adverse effects
such as tendon necrosis or tendon low-grade infection
should be taken into account using intratendinous rather
than extratendinous injections [75]. A recent randomized,
controlled trial in tennis elbow tendinopathy found that
colour doppler guided injections of either polidocanol or
lidocaine plus epinephrine gave similar results in terms of
pain reduction and voluntary grip strength [76]. There-
fore, both volume, dosage and type of agent injected
under colour Doppler control should be in focus for fur-
ther randomized-controlled trials in the treatment of
tendinopathy [77].
Conclusion
Changes of microcirculation are evident in tendinopathy
at the Achilles and the patella tendon as well as in tendi-
onpathies of the upper extremity. Tendon capillary blood
flow is increased at the point of pain correlating to neo-
vascularisation determined by Power Doppler Sonogra-
phy in Achilles tendinopathy (figure 10). Tendon oxygen
saturation as well as tendon postcapillary venous filling
pressures, determined non-invasively using combined
Laser Doppler flowmetry and spectrophotometry, can
identify therapeutic changes or adverse effects on tendon
microcirculation in a real-time quantitative exact way.
Eccentric training decreases pathological increased capil-
lary tendon flow without deterioration of local tendon
microcirculation in Achilles tendinopathy. Further studies
have to focus on challenging therapeutic options, such as
non-invasive nitroglycerine application, non-invasive
laser therapy, and invasive sclerosing therapy in tendinop-
athy.
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